Product Code: RP-ID-10352110 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10352110
Market Overview:
Global Tissue Sectioning Market Analysis & Outlook 2030
The global tissue sectioning/cutting market size in 2021 is estimated at USD 700 million, and the compound annual growth rate is expected to be 7% during the forecast period 2022-2030. The increasing prevalence of chronic diseases and cancer is one of the key factors driving the demand for histopathological tests, because histopathological examinations are essential for the diagnosis of malignant tumors. Cancer is considered to be one of the leading causes of death worldwide. The analysis of biopsy tissue enables pathologists to determine the type, stage of cancer and the extent to which the disease has invaded healthy tissue. This has led to the increasing adoption of histopathology and tissue cutting and staining instruments, which in turn has driven market growth.
The growth of personalized treatment and diagnosis is expected to drive market growth. Personalized medicine is becoming a hallmark of cancer treatment, and its application is expanding to other fields. This is a constantly emerging personalized treatment method based on the accumulation of individual patients; genes.
The increasing popularity of personalized medicine has led to an increase in demand for the use of human tissue, as the field relies on the use of human tissue to develop innovative tests. , The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and the United States Preventive Services Task Force (USPSTF) in cancer detection are key factors driving market growth. Efforts by major market participants to increase awareness of cervical and vaginal cancer screening are expected to herald market growth. For example, the National Health Service (NHS) provides a cervical cancer screening program for all women aged 25 to 64. In the UK, women aged 25 to 49 are usually screened every three years, while women aged 50 to 64 are screened every five years. Receive a screening. The Norwegian government has launched the Norwegian Cervical Cancer Screening Program (NCCSP), which screens women between 25 and 69 years old every three years.
Product insight:
In 2020, the instrument division accounted for more than 50% of the revenue share of the tissue slice market. A microtome and cryostat are required to cut uniform slices of the tissue under study. The advanced version of the microtome can accurately cut tissue blocks from 0.1 to 100 μm in thickness. These devices are available in a variety of shapes, such as sliding, rotating, freezing, ultra and laser microtome. Therefore, the availability of a wide range of products for different purposes in pathology laboratories is expected to drive the growth of this segment. The rotary microtome is the most commonly used instrument in histology laboratories. The development of automated microtome has significantly improved the work efficiency of laboratory personnel, thereby driving the growth of this market segment. Market participants are working hard to improve the reproducibility and work efficiency of slicers and cryostats. The presence of several service providers dedicated to paraffin-embedded tissue sections, allowing the cutting and mounting of very thin sections for microscopic analysis, is expected to drive growth.
Technology insight:
Due to the growing demand for technologically advanced products from developed and developing economies (including Germany, the United States, Japan, France, etc.), the automotive technology sector accounted for the largest market share in 2020. This market segment is also expected to release the fastest compound annual growth rate during the forecast period. The automatic slicer provides users with maximum benefits, reliability and excellent operator comfort. The precision and high slice scalability provided by the automatic microtome make these instruments ideal for slicing paraffin-embedded tissues and hard materials. Therefore, it is easy to adopt automatic instruments in diagnosis, medicine, and other research purposes. Major market players have invested heavily in research and development to update product features and make it easy to use. For example, the touch buttons installed on the device make work efficient and easy. Some key automation products include Tissue-Tek AutoSection, Tissue Surgeon and PT-PC PowerTomes.
Application insight:
The disease diagnosis sector will dominate the market in 2020. The medical research sector is expected to grow at the fastest compound annual growth rate during the forecast period. Histopathological examination of surgical biopsy is considered to be the standard method for diagnosing various diseases, including cancer. Therefore, this method is easily adopted by pathology laboratories all over the world. The researchers made several recommendations to improve the quality of tissue samples used for biopsy during clinical trials. This is because tumor biopsy tissue samples can be used for medical research because they can provide relevant information about the behavior of anticancer drugs in the human body. It is expected that such measures will promote the growth of the medical research field. The existence of several academic and research institutions conducting research in the fields of histology, cytology, and tumor biology is expected to drive market revenue. For example, the Cork Cancer Research Center at the University of Cork in Ireland provides research facilities for tissue processing, embedding, cutting, and staining. The center is equipped with a rotary microtome, which can perform precise tissue cutting during the slide preparation process.
End-use information:
Tissue sections are used in hospitals, small clinics, diagnostic laboratories, and research centers to analyze biopsy samples and other tissues. Due to the influx of biopsy samples for histopathology and cytopathology, and the increase in the number of admissions of cancer patients, the hospital sector occupied the largest market share in 2020. year. In various hospitals and clinics, doctors are shifting from traditional testing procedures to tests based on anatomical pathology. The long turnaround times associated with traditional processes are driving the adoption rate of anatomical pathology-based tests because these help shorten the time frame.
Regional insight:
Due to advanced medical infrastructure, increased investment in tissue diagnostics by the public and private sectors, and widespread adoption of technologically advanced fully automated products, North America will dominate the tissue slice market in 2020. The increase in the prevalence of cancer in North America has driven the demand for cancer diagnostic biopsies, leading to an increase in the demand for tissue cutting equipment. The Asia-Pacific region is expected to witness the fastest compound annual growth rate during the forecast period. The existence of a large number of target populations, a large number of unmet clinical needs, and an increase in advanced diagnostic technology research and development activities are expected to drive regional market growth. In addition, improvements in medical infrastructure and increased medical expenditures are expected to provide a potential growth platform for major manufacturers. The increasing popularity of medical insurance in countries such as India and China is the main market driver. In addition, the existence of well-known companies such as SM Scientific Instruments Pvt. Ltd., AGD Biomedicals and Amos Scientific Pty. Ltd. in countries such as India and Australia is expected to promote the development of the regional market.
Major companies and market share prospects:
Some major market players include Thermo Fisher Scientific, Leica Biosystems Nussloch GmbH, LLS ROWIAK LaserLabSolutions GmbH and Sakura Finetek Europe B.V. These participants participate in the cooperation with the laboratory to maintain a competitive advantage. The initiatives taken by the main participants to solve the processing problems faced by laboratory technicians are expected to solve the organizational problems that have not been adequately addressed. The two companies actively provide specific histological solutions for the isolation of DNA or RNA from FFPE, which are widely used in research fields.
Market segments covered by the report:
The report forecasts global, regional and national revenue growth, and analyzes the latest industry trends in each sub-segment from 2022-2030. For the purpose of this research, Kenneth Research will report on the global tissue slice market based on product, technology, application, end use and region: Product Outlook (Revenue, USD million, 2022-2030) Instrument Rotary Microtome Microtome Sliding Ultra-thin microtome cryostat and other accessories and consumables service technology outlook (revenue, million dollars, 2022-2030) automatic semi-automatic manual application outlook (revenue, million dollars, 2022-2030) diagnostic research end-use outlook (revenue, 100% Million USD, 2022-2030) Hospital Clinic Diagnostic Laboratory Research Center.
Related Reports
Proof of Quality & Reliability
